Matching-Adjusted Indirect Comparisons in the assessment of hemato-oncological drugs José Manuel Martínez-Sesmero, Javier De Castro-Carpeño, Araceli López-de las Heras, Alonso Fernández-Nistal, Francisco Javier Parrondo-García

Evaluation of persistence, retention “rate” and prescription pattern of original infliximab and infliximab CT-P13 in biologic-naïve patients with ulcerative colitis Alejandro Valcuende-Rosique, Joaquín Borrás-Blasco, Sandra Martínez-Badal, Xavier Cortes, Celia Aparicio-Rubio, Elvira Casterá-Melchor

Serum levels of infliximab and adalimumab are associated with deep remission in inflammatory bowel disease Óscar Pascual-Marmaneu, María D. Belles-Medall, Raúl Ferrando-Piqueres, Pedro Almela-Notari, María Mendoza-Aguilera, Tamara Álvarez-Martín